The Fort Worth Press - US court keeps abortion drug available -- for now

USD -
AED 3.672498
AFN 65.999741
ALL 81.749978
AMD 377.657389
ANG 1.79008
AOA 916.50233
ARS 1447.7684
AUD 1.43542
AWG 1.80125
AZN 1.704736
BAM 1.656847
BBD 2.015105
BDT 122.260014
BGN 1.67937
BHD 0.377013
BIF 2953.091775
BMD 1
BND 1.272884
BOB 6.913553
BRL 5.239695
BSD 1.000479
BTN 90.561067
BWP 13.175651
BYN 2.857082
BYR 19600
BZD 2.012224
CAD 1.36883
CDF 2224.999953
CHF 0.77793
CLF 0.021805
CLP 860.999848
CNY 7.97075
CNH 6.94469
COP 3642
CRC 496.003592
CUC 1
CUP 26.5
CVE 93.41048
CZK 20.68325
DJF 178.163135
DKK 6.33544
DOP 63.049753
DZD 129.999028
EGP 46.891297
ERN 15
ETB 154.976835
EUR 0.848335
FJD 2.208987
FKP 0.729917
GBP 0.733985
GEL 2.689736
GGP 0.729917
GHS 10.985781
GIP 0.729917
GMD 73.502583
GNF 8780.996111
GTQ 7.67429
GYD 209.32114
HKD 7.808645
HNL 26.428662
HRK 6.385498
HTG 131.143652
HUF 321.920429
IDR 16818.3
ILS 3.094805
IMP 0.729917
INR 90.493349
IQD 1310.5
IRR 42125.000158
ISK 122.739414
JEP 0.729917
JMD 156.862745
JOD 0.709041
JPY 156.859642
KES 129.170211
KGS 87.449587
KHR 4030.000239
KMF 417.000221
KPW 899.945137
KRW 1464.280435
KWD 0.30738
KYD 0.83376
KZT 497.113352
LAK 21520.880015
LBP 86150.000188
LKR 309.665505
LRD 185.901857
LSL 16.059936
LTL 2.95274
LVL 0.60489
LYD 6.323093
MAD 9.174496
MDL 16.928505
MGA 4431.457248
MKD 52.254146
MMK 2099.936125
MNT 3569.846682
MOP 8.051354
MRU 39.72959
MUR 45.879791
MVR 15.459409
MWK 1737.999994
MXN 17.36365
MYR 3.944005
MZN 63.759784
NAD 16.059961
NGN 1371.402396
NIO 36.81834
NOK 9.707645
NPR 144.897432
NZD 1.67173
OMR 0.384499
PAB 1.000479
PEN 3.362504
PGK 4.286719
PHP 58.840151
PKR 279.84277
PLN 3.577895
PYG 6622.13506
QAR 3.64125
RON 4.3222
RSD 99.574537
RUB 76.24746
RWF 1459.958497
SAR 3.75018
SBD 8.064647
SCR 14.780283
SDG 601.500712
SEK 9.00173
SGD 1.274295
SHP 0.750259
SLE 24.550143
SLL 20969.499267
SOS 570.224434
SRD 37.89403
STD 20697.981008
STN 20.755852
SVC 8.7544
SYP 11059.574895
SZL 16.060355
THB 31.805499
TJS 9.349774
TMT 3.505
TND 2.845503
TOP 2.40776
TRY 43.53032
TTD 6.777163
TWD 31.689501
TZS 2572.500108
UAH 43.151654
UGX 3562.246121
UYU 38.562056
UZS 12264.970117
VES 377.98435
VND 25954.5
VUV 119.556789
WST 2.72617
XAF 555.589718
XAG 0.013059
XAU 0.000206
XCD 2.70255
XCG 1.803149
XDR 0.691101
XOF 555.690911
XPF 101.549983
YER 238.324985
ZAR 16.164855
ZMK 9001.189062
ZMW 19.585153
ZWL 321.999592
  • SCS

    0.0200

    16.14

    +0.12%

  • BCC

    5.3000

    90.23

    +5.87%

  • RBGPF

    4.4200

    86.52

    +5.11%

  • NGG

    1.5600

    87.79

    +1.78%

  • RYCEF

    -0.3100

    16.62

    -1.87%

  • CMSC

    -0.1400

    23.52

    -0.6%

  • BCE

    0.2400

    26.34

    +0.91%

  • RIO

    0.1100

    96.48

    +0.11%

  • BTI

    -0.2400

    61.63

    -0.39%

  • GSK

    3.8900

    57.23

    +6.8%

  • VOD

    0.4600

    15.71

    +2.93%

  • JRI

    0.0300

    13.15

    +0.23%

  • CMSD

    -0.0700

    23.87

    -0.29%

  • RELX

    -0.7300

    29.78

    -2.45%

  • BP

    0.3800

    39.2

    +0.97%

  • AZN

    3.1300

    187.45

    +1.67%

US court keeps abortion drug available -- for now
US court keeps abortion drug available -- for now / Photo: © AFP/File

US court keeps abortion drug available -- for now

A US appeals court has blocked moves to ban a widely-used abortion pill -- but imposed tough restrictions on access, in the latest round of an intensifying battle over reproductive rights.

Text size:

The ruling issued late Wednesday preserves access for now to mifepristone -- used for more than half of all abortions in the United States -- but a question mark remains over its long-term availability in a case likely to go all the way to Supreme Court.

The new order limits access to women in the first seven weeks of pregnancy, down from 10; it requires in-person visits to obtain the pill -- a requirement lifted in recent years; and it blocks the medication from being sent by mail.

Wednesday's 2-1 ruling by a federal appeals court in New Orleans, Louisiana, came after a Texas judge overturned the Food and Drug Administration's (FDA) two-decades old approval of the drug last Friday.

The appellate court said its ruling would hold until the case was heard in full -- likely by the Supreme Court.

The latest standoff over women's reproductive freedom in America comes almost a year after the conservative-dominated Supreme Court overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.

- 'Commitment to women' -

US President Joe Biden has branded the Texas ruling as "out of bounds," and his spokeswoman, Karine Jean-Pierre, said Thursday the administration would continue fighting it in court.

"We believe that the law is on our side, and we will prevail," she told reporters during the president's visit to Dublin, Ireland.

"I can reassure the American people that that is our commitment to women ... to make sure that women are able to make decisions for themselves about their own body," she added.

Democrats and activists warn the Texas ruling -- issued by a judge appointed by former Republican president Donald Trump -- moves the nation one step closer to a nationwide abortion ban sought by many conservatives.

Judge Matthew Kacsmaryk's ruling came after a coalition of anti-abortion groups sued to freeze the national distribution of mifepristone.

The Texas judge, in his decision, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."

Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.

But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.

Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access the procedure -- or ban it outright.

The two New Orleans judges who voted to tighten restrictions on access, Kurt Engelhardt and Andrew Oldham, were also both appointed by Trump.

The third, Catharina Haynes, is an appointee of former president George W. Bush.

Shortly after the initial Texas decision, a judge in Washington state ruled in a separate case that access to mifepristone must be preserved. The dueling opinions, along with the appeals, mean the issue is almost certain to end up before the Supreme Court.

M.T.Smith--TFWP